STSS | Sharps Technology, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	5.30 - 7.39
52 Week Range	3.30 - 5,445.00
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	19,350,475
Average Volume	368,173
Shares Outstanding	54,446
Market Cap	305,442
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	2022-04-14

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	-2,220.00
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	57
Country	USA
Website	STSS

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

STSS's peers: GCTK, BNGO, MBOT, NXGL, POAI, STSSW, ZJYL, MHUA, GMVD, LUCY, AVGR, POCI, KRMD, INFU, UTMD, MLSS

*Chart delayed

Analyzing fundamentals for STSS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see STSS Fundamentals page.

Watching at STSS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on STSS Technicals page.